Development of new treatment modality for diabetic macular edema using knockout mice that show prominent retinal edema.
Project/Area Number |
20390447
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Ophthalmology
|
Research Institution | Shinshu University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
SHINDO Takayuki 信州大学, 医学系研究科, 教授 (90345215)
ISHIBASHI Tatsuro 九州大学, 医学系研究科, 教授 (30150428)
|
Project Period (FY) |
2008 – 2010
|
Project Status |
Completed (Fiscal Year 2010)
|
Budget Amount *help |
¥15,470,000 (Direct Cost: ¥11,900,000、Indirect Cost: ¥3,570,000)
Fiscal Year 2010: ¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2009: ¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2008: ¥5,720,000 (Direct Cost: ¥4,400,000、Indirect Cost: ¥1,320,000)
|
Keywords | 眼細胞生物学糖尿病黄斑浮腫治療 / 糖尿病黄斑浮腫 / アドレノメデュリン / ノックアウトマウス / RAMP-2 / 糖尿病網膜症 / 糖尿病 / タイトジャンクション / 基底膜 / 黄斑浮腫 |
Research Abstract |
Homozygote RAMP-2 knockout(KO) mice are fatal before delivery, but heterozygote RAMP-2 KO mice show largely normal development except for systemic edema. We found these mice have marked retinal edema. Diabetic retinal edema is a leading cause of legal blindness. There has been no animal model for retinal edema.(RAMP)-2 knockout mice are new and the only existing animal model of retinal edema. Using this model, we reported that insufficient formation of tight junction and disruption of Bruch' s membrane are potential causes of breakdown of blood-retinal barrier.
|
Report
(5 results)
Research Products
(28 results)
-
-
-
-
-
-
-
-
-
-
[Journal Article] Stable Retinal Gene Expression in Nonhuman Primates via Subretinal Injection of SIVagm-based Lentiviral Vectors2009
Author(s)
Ikeda Y, Murata T, Tabata T, Ueda Y, Ono F, Suzuki T, Ageyama N, Terao K, Hasegawa M, Sueishi K, Ishibashi T
-
Journal Title
Hum Gene Ther
Volume: 20(6)
Pages: 573-579
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-